Promising growth and investment in the cell therapy industry during the first quarter of 2012

Cell Stem Cell. 2012 May 4;10(5):492-6. doi: 10.1016/j.stem.2012.04.018.


In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Transplantation / economics*
  • Cell Transplantation / trends*
  • Health Care Sector*
  • Humans
  • Investments
  • United States